1403458-93-4

Upstream product

• 1403458-86-5 (R)-tert-butyl 2-(6-(methoxycarbonyl)-2-(2-methylmorpholino)-4-oxo-4H-chromen-8-yl)-1H-pyrrole-1-carboxylate 
• 1296271-67-4 methyl 8-bromo-2-(ethylsulfonyl)-4-oxo-4H-chromene-6-carboxylate 
• 1296271-66-3 methyl 8-bromo-2-(ethylthio)-4-oxo-4H-chromene-6-carboxylate 
• 1296271-65-2 methyl 8-bromo-4-hydroxy-2-thioxo-2H-chromene-6-carboxylate 
• 71407-98-2 3-acetyl-5-bromo-4-hydroxybenzoic acid 
• 1296271-68-5 methyl 8-bromo-2-((R)-2-methylmorpholino)-4-oxo-4H-chromene-6-carboxylate 
• 57009-12-8 methyl 3-acetyl-4-hydroxybenzoate 
• 160753-84-4 methyl 3-acetyl-5-bromo-4-hydroxybenzoate 
• 845795-75-7 (R)-4-benzyl-2-methylmorpholine hydrochloride 
• 1004517-04-7 (R)-1-(benzyl(2-hydroxyethyl)amino)propan-2-ol 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 1403458-88-7 tert-butyl 2-(6-(methoxycarbonyl)-2-((R)-2-methylmorpholino)-4-oxo-4H-chromen-8-yl)pyrrolidine-1-carboxylate 

Relevant academic research and scientific papers

CHROMENONE COMPOUNDS AS PI 3 -KINASE INHIBITORS FOR THE TREATMENT OF CANCER

The invention concerns chromenone compounds of Formula I; or pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, n and R6 has any of the meanings defined hereinbe

CHROMENONE DERIVATIVES

The invention concerns chromenone compounds of Formula I; or pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, n and R6 has any of the meanings defined hereinbe